Quel est le prix pour Levitee Labs Inc. (LVT)

Le prix pour Levitee Labs Inc. (LVT) est $0.00366968

Quelle est la capitalisation boursière pour Levitee Labs Inc. (LVT)

La capitalisation boursière pour Levitee Labs Inc. (LVT) est $368.50K

Levitee Labs Inc. (LVT) Ratio P/B

Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019, functions as a comprehensive wellness enterprise. The company is dedicated to delivering evidence-backed alternative medical treatments and pioneering psychedelic therapies, operating through its Medical Services and Selling Products divisions. Within its medical operations, Levitee Labs provides care and prescriptions for a range of conditions, including substance use disorders, various chronic pain conditions such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, in addition to Hepatitis-C and diverse mental health issues. This segment encompasses the management of five Levitee Clinics and three Levitee Pharmacies situated in Alberta. Furthermore, the company facilitates electronic prescriptions for addiction treatment via its BlockMD platform and distributes a selection of wholesale supplements and superfoods under the Earth Circle Organics brand. The organization adopted its current name, Levitee Labs Inc., on November 30, 2020, having previously been known as Fibonacci Capital Corp.

Année	Ratio P/B	Changez
Pas assez de données pour les dates fournies.

Année

Ratio P/B

Changez

Pas assez de données pour les dates fournies.

Entreprise	Ratio P/B	Différence de Ratio P/B	Pays
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5.7207	-	IN

Entreprise

Ratio P/B

Différence de Ratio P/B

Pays